Companies / Lyell Immunopharma, Inc. / Activity
Activity — Lyell Immunopharma, Inc.
10 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | Seely Lynn CEO | Sell | Common Stock | $174.4K | -7K -9.12% | 74,266 0.30% of shares | medium |
| Dec 24, 2025 | Bulis Veronica Sanchez Executive | Sell | Common Stock | $43.9K | -1K -12.33% | 8,077 0.03% of shares | low |
| Feb 11, 2026 | Lee Gary K. Executive | Sell | Common Stock | $39.1K | -2K -8.98% | 16,938 0.07% of shares | low |
| Dec 30, 2025 | Bulis Veronica Sanchez Executive | Sell | Common Stock | $30.3K | -936 -11.59% | 7,141 0.03% of shares | low |
| Feb 11, 2026 | Hill Stephen J. Executive | Sell | Common Stock | $28.9K | -1K -6.49% | 17,795 0.07% of shares | low |
| Feb 10, 2026 | Seely Lynn CEO | Sell | Common Stock | $10.1K | -438 -0.53% | 81,721 0.33% of shares | low |
| May 11, 2026 | Seely Lynn CEO | Sell | Common Stock | $7.3K | -388 -0.52% | 73,878 0.30% of shares | low |
| Feb 10, 2026 | Bulis Veronica Sanchez Executive | Sell | Common Stock | $5.9K | -254 -1.60% | 15,637 0.06% of shares | low |
| Feb 10, 2026 | Lee Gary K. Executive | Sell | Common Stock | $3.4K | -147 -0.78% | 18,609 0.08% of shares | low |
| Feb 10, 2026 | Hill Stephen J. Executive | Sell | Common Stock | $2.5K | -109 -0.57% | 19,031 0.08% of shares | low |